Symbols / HUMA $0.85 -19.42%
HUMA Chart
About
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 164.84M |
| Enterprise Value | 191.43M | Income | -36.97M | Sales | 1.57M |
| Book/sh | -0.03 | Cash/sh | 0.10 | Dividend Yield | — |
| Payout | 0.00% | Employees | 218 | IPO | — |
| P/E | — | Forward P/E | -1.62 | PEG | — |
| P/S | 104.93 | P/B | -28.47 | P/C | — |
| EV/EBITDA | -1.97 | EV/Sales | 121.85 | Quick Ratio | 0.80 |
| Current Ratio | 1.62 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.27 | EPS next Y | -0.53 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-27 | ROA | -63.44% |
| ROE | — | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | -32.39% | Profit Margin | 0.00% | Shs Outstand | 193.00M |
| Shs Float | 157.04M | Short Float | 22.11% | Short Ratio | 6.71 |
| Short Interest | — | 52W High | 3.36 | 52W Low | 0.81 |
| Beta | 1.93 | Avg Volume | 5.19M | Volume | 52.13M |
| Target Price | $7.71 | Recom | Strong_buy | Prev Close | $1.06 |
| Price | $0.85 | Change | -19.42% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$7.71
Mean price target
2. Current target
$0.85
Latest analyst target
3. DCF / Fair value
$-6.92
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.85
Low
$3.00
High
$25.00
Mean
$7.71
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-19 | main | D. Boral Capital | Buy → Buy | $25 |
| 2026-03-17 | main | D. Boral Capital | Buy → Buy | $25 |
| 2026-02-19 | main | D. Boral Capital | Buy → Buy | $25 |
| 2026-02-10 | reit | BTIG | Buy → Buy | $6 |
| 2026-02-09 | main | D. Boral Capital | Buy → Buy | $25 |
| 2026-01-21 | main | Benchmark | Buy → Buy | $10 |
| 2026-01-08 | main | D. Boral Capital | Buy → Buy | $25 |
| 2026-01-05 | main | D. Boral Capital | Buy → Buy | $25 |
| 2025-12-22 | main | D. Boral Capital | Buy → Buy | $25 |
| 2025-11-21 | reit | BTIG | Buy → Buy | $6 |
| 2025-11-20 | main | D. Boral Capital | Buy → Buy | $25 |
| 2025-11-13 | main | Benchmark | Buy → Buy | $11 |
| 2025-11-13 | main | D. Boral Capital | Buy → Buy | $25 |
| 2025-11-12 | main | D. Boral Capital | Buy → Buy | $25 |
| 2025-11-10 | main | D. Boral Capital | Buy → Buy | $25 |
| 2025-10-13 | main | BTIG | Buy → Buy | $6 |
| 2025-10-06 | main | D. Boral Capital | Buy → Buy | $25 |
| 2025-09-30 | main | D. Boral Capital | Buy → Buy | $25 |
| 2025-09-18 | main | D. Boral Capital | Buy → Buy | $25 |
| 2025-09-15 | main | D. Boral Capital | Buy → Buy | $25 |
- Humacyte Secures $1.5M Saudi Order – Why Did HUMA Stock Crash To Record Low Today? - Stocktwits hu, 19 Mar 2026 16
- Humacyte (Nasdaq: HUMA) prices $20M registered direct stock sale - Stock Titan hu, 19 Mar 2026 20
- Humacyte (HUMA) Projected to Post Quarterly Earnings on Friday - MarketBeat Fri, 20 Mar 2026 05
- Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock - Yahoo Finance Singapore hu, 19 Mar 2026 12
- Humacyte Announces $20 Million Registered Direct Offering - TipRanks hu, 19 Mar 2026 21
- HUMA Drops 19.6%: Sharp Downturn Triggered by $20M Sale Amid Market Turbulence - Bitget hu, 19 Mar 2026 14
- Humacyte stock rating reiterated at Buy by D. Boral Capital - Investing.com ue, 17 Mar 2026 15
- Humacyte: Positive News For Symvess At Last, But Long-Term Threats Persist (NASDAQ:HUMA) - Seeking Alpha Mon, 09 Feb 2026 08
- Humacyte (HUMA): Benchmark Remains Bullish on Stock - Yahoo Finance Wed, 10 Dec 2025 08
- Saudi hospitals to evaluate Humacyte vessel under $1.475M deal - Stock Titan hu, 19 Mar 2026 12
- Humacyte Ends ATM Program, Highlights Symvess Global Expansion - TipRanks hu, 19 Mar 2026 12
- Humacyte (NASDAQ: HUMA) to raise $20M selling 25M shares at $0.80 - Stock Titan hu, 19 Mar 2026 20
- Is Humacyte, Inc. (HUMA) Outperforming Other Medical Stocks This Year? - Yahoo Finance Wed, 07 Jan 2026 08
- Bioengineered tissue firm Humacyte lines up back-to-back March investor talks - Stock Titan Mon, 02 Mar 2026 08
- Should You Invest in Humacyte, Inc. (HUMA) Based on Bullish Wall Street Views? - Yahoo Finance Fri, 14 Nov 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 311100 | — | — | Stock Award(Grant) at price 0.00 per share. | SANDER DALE A | Chief Financial Officer | — | 2025-11-14 00:00:00 | D |
| 1 | 311100 | — | — | Stock Award(Grant) at price 0.00 per share. | PARIKH SHAMIK J | Officer | — | 2025-11-14 00:00:00 | D |
| 2 | 2241045 | 3733191 | — | Sale at price 1.58 - 1.83 per share. | DOUGAN BRADY W | Director | — | 2025-08-20 00:00:00 | I |
| 3 | 2241045 | 3733191 | — | Sale at price 1.58 - 1.83 per share. | NIKLASON LAURA E | Chief Executive Officer | — | 2025-08-20 00:00:00 | I |
| 4 | 6493 | 9999 | — | Purchase at price 1.54 per share. | SCHEESSELE WILLIAM JOHN | Officer | — | 2025-04-14 00:00:00 | D |
| 5 | 20000 | 30600 | — | Purchase at price 1.53 per share. | SANDER DALE A | Chief Financial Officer | — | 2025-04-10 00:00:00 | I |
| 6 | 7500 | 11625 | — | Purchase at price 1.55 per share. | PARIKH SHAMIK J | Officer | — | 2025-04-10 00:00:00 | D |
| 7 | 50000 | 66000 | — | Purchase at price 1.32 per share. | SEBELIUS KATHLEEN G | Director | — | 2025-04-08 00:00:00 | D |
| 8 | 6000 | 7740 | — | Purchase at price 1.29 per share. | GREEN CHARLES BRUCE | Director | — | 2025-04-08 00:00:00 | D |
| 9 | 16000 | 20160 | — | Purchase at price 1.26 per share. | CONSTANTINO MICHAEL T | Director | — | 2025-04-07 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -103.10M | -86.86M | -73.74M | -72.95M |
| TotalUnusualItems | -29.13M | -9.60M | 76.18M | 59.06M |
| TotalUnusualItemsExcludingGoodwill | -29.13M | -9.60M | 76.18M | 59.06M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -148.70M | -110.78M | -11.96M | -26.48M |
| ReconciledDepreciation | 7.19M | 7.72M | 8.21M | 8.24M |
| EBITDA | -132.23M | -96.46M | 2.44M | -13.89M |
| EBIT | -139.42M | -104.18M | -5.76M | -22.13M |
| NetInterestIncome | -5.17M | -1.13M | -3.57M | -4.33M |
| InterestExpense | 9.28M | 6.60M | 6.20M | 4.35M |
| InterestIncome | 4.10M | 5.47M | 2.63M | 16.00K |
| NormalizedIncome | -119.57M | -101.18M | -88.15M | -85.54M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -148.70M | -110.78M | -11.96M | -26.48M |
| TotalExpenses | 114.40M | 100.05M | 84.58M | 81.21M |
| TotalOperatingIncomeAsReported | -114.40M | -100.05M | -84.58M | -81.21M |
| DilutedAverageShares | 118.48M | 103.42M | 103.05M | 39.97M |
| BasicAverageShares | 118.48M | 103.42M | 103.05M | 39.97M |
| DilutedEPS | -1.26 | -1.07 | -0.12 | -0.66 |
| BasicEPS | -1.26 | -1.07 | -0.12 | -0.66 |
| DilutedNIAvailtoComStockholders | -148.70M | -110.78M | -11.96M | -26.48M |
| NetIncomeCommonStockholders | -148.70M | -110.78M | -11.96M | -26.48M |
| NetIncome | -148.70M | -110.78M | -11.96M | -26.48M |
| NetIncomeIncludingNoncontrollingInterests | -148.70M | -110.78M | -11.96M | -26.48M |
| NetIncomeContinuousOperations | -148.70M | -110.78M | -11.96M | -26.48M |
| PretaxIncome | -148.70M | -110.78M | -11.96M | -26.48M |
| OtherIncomeExpense | -29.13M | -9.60M | 76.18M | 59.06M |
| SpecialIncomeCharges | -33.05M | -9.34M | 75.77M | 59.01M |
| OtherSpecialCharges | -686.00K | -3.28M | ||
| RestructuringAndMergernAcquisition | 33.05M | 10.02M | -75.77M | -55.72M |
| GainOnSaleOfSecurity | 3.92M | -260.00K | 417.00K | 56.00K |
| NetNonOperatingInterestIncomeExpense | -5.17M | -1.13M | -3.57M | -4.33M |
| InterestExpenseNonOperating | 9.28M | 6.60M | 6.20M | 4.35M |
| InterestIncomeNonOperating | 4.10M | 5.47M | 2.63M | 16.00K |
| OperatingIncome | -114.40M | -100.05M | -84.58M | -81.21M |
| OperatingExpense | 114.40M | 100.05M | 84.58M | 81.21M |
| OtherOperatingExpenses | -1.56M | -1.26M | ||
| ResearchAndDevelopment | 88.60M | 76.55M | 63.26M | 61.34M |
| SellingGeneralAndAdministration | 25.80M | 23.50M | 22.88M | 21.13M |
| GeneralAndAdministrativeExpense | 25.80M | 23.50M | 22.88M | 21.13M |
| OtherGandA | 25.80M | 23.50M | 22.88M | 21.13M |
| SalariesAndWages | -3.11M | 0.00 | ||
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 130.03M | 103.67M | 103.23M | 103.00M |
| ShareIssued | 130.03M | 103.67M | 103.23M | 103.00M |
| TotalDebt | 16.54M | 18.85M | 50.07M | 51.18M |
| TangibleBookValue | -52.67M | 13.55M | 116.93M | 122.17M |
| InvestedCapital | -52.67M | 13.55M | 145.84M | 149.53M |
| WorkingCapital | 27.91M | 64.83M | 134.63M | 218.29M |
| NetTangibleAssets | -52.67M | 13.55M | 116.93M | 122.17M |
| CapitalLeaseObligations | 16.54M | 18.85M | 21.16M | 23.82M |
| CommonStockEquity | -52.67M | 13.55M | 116.93M | 122.17M |
| TotalCapitalization | -52.67M | 13.55M | 137.26M | 149.53M |
| TotalEquityGrossMinorityInterest | -52.67M | 13.55M | 116.93M | 122.17M |
| StockholdersEquity | -52.67M | 13.55M | 116.93M | 122.17M |
| RetainedEarnings | -686.01M | -537.31M | -426.54M | -414.57M |
| AdditionalPaidInCapital | 633.33M | 550.85M | 543.46M | 536.74M |
| CapitalStock | 13.00K | 10.00K | 10.00K | 10.00K |
| CommonStock | 13.00K | 10.00K | 10.00K | 10.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 190.54M | 114.68M | 87.37M | 164.36M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 170.59M | 96.23M | 67.79M | 153.31M |
| OtherNonCurrentLiabilities | 135.30M | 77.23M | 28.61M | 103.66M |
| PreferredSecuritiesOutsideStockEquity | 0.00 | |||
| DerivativeProductLiabilities | 21.67M | 2.71M | 0.00 | 497.00K |
| NonCurrentDeferredLiabilities | 0.00 | |||
| NonCurrentDeferredTaxesLiabilities | 0.00 | |||
| LongTermDebtAndCapitalLeaseObligation | 13.62M | 16.29M | 39.19M | 49.15M |
| LongTermCapitalLeaseObligation | 13.62M | 16.29M | 18.85M | 21.79M |
| LongTermDebt | 38.60M | 20.34M | 27.36M | |
| CurrentLiabilities | 19.95M | 18.44M | 19.58M | 11.05M |
| OtherCurrentLiabilities | 1.12M | 53.00K | ||
| CurrentDeferredLiabilities | 0.00 | 173.00K | ||
| CurrentDeferredTaxesLiabilities | 0.00 | 173.00K | ||
| CurrentDebtAndCapitalLeaseObligation | 2.92M | 2.56M | 10.88M | 2.03M |
| CurrentCapitalLeaseObligation | 2.92M | 2.56M | 2.31M | 2.03M |
| CurrentDebt | 8.57M | |||
| OtherCurrentBorrowings | 8.57M | |||
| PensionandOtherPostRetirementBenefitPlansCurrent | 6.24M | 5.24M | 4.23M | 3.94M |
| PayablesAndAccruedExpenses | 9.67M | 10.59M | 4.48M | 4.91M |
| CurrentAccruedExpenses | 5.18M | 4.10M | 2.88M | 2.81M |
| Payables | 4.49M | 6.49M | 1.59M | 2.09M |
| AccountsPayable | 4.49M | 6.49M | 1.59M | 2.09M |
| TotalAssets | 137.87M | 128.22M | 204.30M | 286.53M |
| TotalNonCurrentAssets | 90.01M | 44.95M | 50.09M | 57.19M |
| OtherNonCurrentAssets | 51.46M | 841.00K | ||
| NetPPE | 38.55M | 44.10M | 50.09M | 57.19M |
| AccumulatedDepreciation | -36.09M | -31.33M | -26.18M | -20.44M |
| GrossPPE | 74.64M | 75.43M | 76.28M | 77.63M |
| Leases | 27.90M | 27.84M | 26.36M | 26.36M |
| ConstructionInProgress | 0.00 | 680.00K | 0.00 | |
| OtherProperties | 44.55M | 45.71M | 47.88M | 49.80M |
| MachineryFurnitureEquipment | 2.19M | 1.87M | 1.36M | 1.48M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 47.86M | 83.28M | 154.21M | 229.34M |
| OtherCurrentAssets | 2.92M | 2.83M | 2.30M | 3.66M |
| PrepaidAssets | 3.66M | |||
| Receivables | 0.00 | 31.00K | 176.00K | |
| AccountsReceivable | 0.00 | 31.00K | 176.00K | |
| CashCashEquivalentsAndShortTermInvestments | 44.94M | 80.45M | 151.88M | 225.50M |
| OtherShortTermInvestments | 0.00 | 2.11M | 8.00M | |
| CashAndCashEquivalents | 44.94M | 80.45M | 149.77M | 217.50M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -99.69M | -75.58M | -72.18M | -81.41M |
| RepaymentOfDebt | -2.58M | -34.07M | -1.98M | -1.73M |
| IssuanceOfDebt | 0.00 | 29.66M | ||
| IssuanceOfCapitalStock | 89.05M | 0.00 | ||
| CapitalExpenditure | -1.57M | -2.28M | -1.05M | -220.00K |
| InterestPaidSupplementalData | 0.00 | 1.61M | 2.67M | 1.12M |
| EndCashPosition | 95.29M | 80.80M | 149.77M | 217.50M |
| BeginningCashPosition | 80.80M | 149.77M | 217.50M | 39.93M |
| ChangesInCash | 14.49M | -68.97M | -67.73M | 177.57M |
| FinancingCashFlow | 114.18M | 4.51M | -1.45M | 266.98M |
| CashFlowFromContinuingFinancingActivities | 114.18M | 4.51M | -1.45M | 266.98M |
| NetOtherFinancingCharges | 19.39M | 38.01M | 238.46M | |
| ProceedsFromStockOptionExercised | 8.32M | 566.00K | 535.00K | 598.00K |
| NetPreferredStockIssuance | 43.13M | 0.00 | ||
| PreferredStockIssuance | 43.13M | 0.00 | ||
| NetCommonStockIssuance | 45.93M | 0.00 | ||
| CommonStockIssuance | 45.93M | 0.00 | ||
| NetIssuancePaymentsOfDebt | -2.58M | -34.07M | -1.98M | 27.93M |
| NetLongTermDebtIssuance | -2.58M | -34.07M | -1.98M | 27.93M |
| LongTermDebtPayments | -2.58M | -34.07M | -1.98M | -1.73M |
| LongTermDebtIssuance | 0.00 | 29.66M | ||
| InvestingCashFlow | -1.57M | -173.00K | 4.84M | -8.22M |
| CashFlowFromContinuingInvestingActivities | -1.57M | -173.00K | 4.84M | -8.22M |
| NetInvestmentPurchaseAndSale | 0.00 | 2.11M | 5.89M | -8.00M |
| SaleOfInvestment | 0.00 | 2.11M | 16.00M | 0.00 |
| PurchaseOfInvestment | 0.00 | -10.11M | -8.00M | |
| NetPPEPurchaseAndSale | -1.57M | -2.28M | -1.05M | -220.00K |
| SaleOfPPE | 0.00 | |||
| PurchaseOfPPE | -1.57M | -2.28M | -1.05M | -220.00K |
| OperatingCashFlow | -98.12M | -73.31M | -71.13M | -81.19M |
| CashFlowFromContinuingOperatingActivities | -98.12M | -73.31M | -71.13M | -81.19M |
| ChangeInWorkingCapital | 311.00K | 6.57M | 1.03M | -557.00K |
| ChangeInOtherWorkingCapital | -173.00K | -116.00K | ||
| ChangeInOtherCurrentLiabilities | -53.00K | -50.00K | -45.00K | -42.00K |
| ChangeInPayablesAndAccruedExpense | 276.00K | 6.98M | -262.00K | 1.84M |
| ChangeInAccruedExpense | 2.24M | 2.17M | 247.00K | 2.04M |
| ChangeInPayable | -1.96M | 4.81M | -509.00K | -197.00K |
| ChangeInAccountPayable | -1.96M | 4.81M | -509.00K | -197.00K |
| ChangeInPrepaidAssets | 88.00K | -388.00K | 1.36M | -2.17M |
| ChangeInReceivables | 0.00 | 31.00K | 145.00K | -63.00K |
| ChangesInAccountReceivables | 0.00 | 31.00K | 145.00K | -63.00K |
| OtherNonCashItems | 40.85M | 13.65M | -74.18M | -54.74M |
| StockBasedCompensation | 6.14M | 6.83M | 6.18M | 10.15M |
| AssetImpairmentCharge | 0.00 | -14.46M | ||
| DepreciationAmortizationDepletion | 7.19M | 7.72M | 8.21M | 8.24M |
| DepreciationAndAmortization | 7.19M | 7.72M | 8.21M | 8.24M |
| AmortizationCashFlow | 2.09M | 2.06M | 2.06M | 2.06M |
| AmortizationOfIntangibles | 2.09M | 2.06M | 2.06M | 2.06M |
| Depreciation | 5.10M | 5.66M | 6.15M | 6.18M |
| OperatingGainsLosses | -3.91M | 2.70M | -411.00K | -3.34M |
| GainLossOnInvestmentSecurities | -3.92M | 260.00K | -417.00K | -56.00K |
| GainLossOnSaleOfPPE | 4.00K | 18.00K | 6.00K | 0.00 |
| NetIncomeFromContinuingOperations | -148.70M | -110.78M | -11.96M | -26.48M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for HUMA
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|